Base editing gene therapy is rewriting the future for sickle cell patients, leaving them healthier and pain-free.

"The education was not there. It still isn't there, but it should be," Alvin Henry Jr., a sickle cell disease patient, said. ...

J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...

Transplant is beneficial earlier in life, Wang told MedPage Today, but carries potential short- and long-term side effects.

Nearly all the patients with severe SCD treated with the gene-editing therapy reni-cel remained free of VOEs for up to two ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...

The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...

Data from a Phase 2/3 trial shows etavopivat may reduce the incidence of vaso-occlusive crises and raise levels of hemoglobin ...

The Indianapolis Colts and Versiti Blood Center of Indiana on Friday hosted the 25th annual Bleed Blue Blood drive.